Re-examination of clinical aspects of pharmacoeconomic analysis.
Rubenstein
E B
EB
Elting
L S
LS
D000970:Antineoplastic Agents / Q000009:adverse effects; D017850:Economics, Pharmaceutical; D006801:Humans; D008787:Metoclopramide / Q000191:economics / Q000627:therapeutic use; D017294:Ondansetron / Q000191:economics / Q000627:therapeutic use; D010601:Pharmacology, Clinical; D012680:Sensitivity and Specificity; D014839:Vomiting / Q000139:chemically induced / Q000517:prevention & control
D000970:Antineoplastic Agents; D017294:Ondansetron; D008787:Metoclopramide